Funding Grows For Indy-Connected Biopharma Company

Posted: Updated:
Outpost Medicine was launched in 2016. Outpost Medicine was launched in 2016.
INDIANAPOLIS and LONDON -

A biopharmaceutical company with offices in Indianapolis and London has announced a $20 million boost to a Series A round of financing. Outpost Medicine, which focuses on treating urologic and gastrointestinal disorders, also says Scott Byrd will succeed co-founder David Socks as president and chief executive officer. Socks, who also serves as a venture partner with one of Outpost's key VC providers, Frazier Healthcare Partners, will remain on the board of directors.

Byrd most recently served as president and chief operating officer of United Kingdom-based Acacia Pharma Inc. and his 25 years of pharmaceutical industry experience also includes time as senior vice president and chief commercial officer of Mallinckrodt PLC (NYSE: MNK) subsidiary Cadence Pharmaceuticals and various positions at Indianapolis-based Eli Lilly and Co. (NYSE: LLY).

The company's Series A total is now valued at $61 million. New investor Takeda Ventures joined existing Outpost investors Frazier Healthcare Partners, Novo Holdings A/S, Vivo Capital and Adams Street Partners on the extended financial backing.

Outpost Chairman Tachi Yamada says "Scott has a proven record of success across commercialization, development, manufacturing, and capital markets, which we expect will greatly benefit Outpost as we advance our pipeline of novel therapeutics." He adds "proceeds from the Series A extension enable Outpost to shift focus to OP-687, a new class of oral therapy in development for the treatment overactive bladder and irritable bowel syndrome. We believe OP-687 holds great potential to significantly improve the care of patients with OAB and IBS, disorders that affect over 1 in 10 people worldwide."

The company was formed in March of 2016 through a partnership with Japan-based Takeda Pharmaceutical Co. Ltd. and Frazier Healthcare Partners. Outpost was launched as the exclusive global development and commercialization licensee of a clinical-stage candidate being studied to treat stress urinary incontinence called OP-233. In the company's announcement of its funding extension, it also announced the discontinuation of the OP-233 program.

  • Perspectives

    • An Antidote For First-Time Homebuyer Jitters

      If you're a Millennial like I am, chances are you're in the market to purchase your first home. It's exciting!  But since it's most likely the largest purchase you've ever made, it can quickly turn into a nerve-racking endeavor. Having just completed a transaction, I found that following these guidelines can ensure a smooth process. Every homebuyer's experience will be different because of a number of variables such as what state you live in and the condition of the housing mark...
    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • (Image of Gene Renuart courtesy of the Indiana Innovation Institute.)

      Agreement Paves Way For More Trusted Microelectronics Collaboration

      A new four-way partnership aims to boost the state's national position in the field of trusted microelectronics. The Indiana Innovation Institute, the Crane Naval Surface Warfare Center, Indiana University and Purdue University have inked a cooperative research and development agreement that officials say will drive research, talent and economic development. The collaboration will work to develop microelectronics that are...

    • The Finish Line Acquisition Complete

      The nearly $560 million acquisition of Indianapolis-based The Finish Line Inc. is complete. The deal by JD Sports Fashion plc, a retailer headquartered in the United Kingdom, was announced in March. Finish Line shareholders last week approved the transaction. The Finish Line is now a wholly-owned subsidiary of JD Sports. Finish Line Chief Executive Officer Sam Sato will remain with the surviving corporation and will maintain a seat with the board of directors.

    • (Image courtesy of IU Health West.)

      IU Health West President Updates $80M Expansion

      As executives continue to receive feedback about an $80 million expansion of Indiana University Health West Hospital in Avon, newly-appointed President Art Vasquez says the project is focused on the future. Plans call for four dozen additional beds, a new operating room and additional laboratory and support service space. Vasquez tells Inside INdiana Business capacity issues at the 14-year-old Hendricks County facility have led to hundreds of patients a year being transported elsewhere.

    • Delta Begins Nonstop to Seattle

      Delta Air Lines now offers a nonstop flight from Indianapolis International to Seattle-Tacoma International Airport. The first flight leaving Monday night will be a milestone for the Indy airport, since it will now connect to all Delta hubs in the U.S. 

    • (photo courtesy of our partners at the Daily Journal)

      Bargersville Company to Partially Relocate

      A nearly 80-year-old company in Johnson County is looking to expand. Our partners at the Daily Journal report Bargersville-based Roy Umbarger and Sons is planning to invest $13 million to relocate its feed division to a site near Franklin.